Journal of Pharmaceutical Policy and Practice
Perceptions and trends in the use of community pharmacies in Ghana
To examine the patterns in utilization of community pharmacies and perceptions of the general public towards community pharmacists’ role in health services delivery.Journal of Pharmaceutical Policy and Practice 2019 12:25Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations
Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan. The 2011 “Fake Drug Crisis” acted as a ...Journal of Pharmaceutical Policy and Practice 2019 12:23Assessing national governance of medicine promotion: an exploratory study in Ghana to trial a structured set of indicators
Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting their ability to attain optimal health outcomes. Acces...Journal of Pharmaceutical Policy and Practice 2019 12:26Systematic review for the development of a pharmaceutical and medical products prioritization framework
To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.Journal of Pharmaceutical Policy and Practice 2019 12:21The Brazilian private pharmaceutical market after the first ten years of the generics law
To describe changes in the private market for selected originators, branded generics (‘similares’), and generic products during the 10 years following passage of the Brazilian Generics Law.Journal of Pharmaceutical Policy and Practice 2019 12:18Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators
Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulati...Journal of Pharmaceutical Policy and Practice 2019 12:19- Journal of Pharmaceutical Policy and Practice 2019 12:20
Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal
The rational use of medicine improves patient’s quality of life. Excessive and inappropriate prescriptions result in severe consequences. The study of drug use patterns and prescription errors is necessary to ...Journal of Pharmaceutical Policy and Practice 2019 12:16Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
As part of the initiatives to increase price transparency for consumers, pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and recommended retail prices (RRP) of medicines to th...Journal of Pharmaceutical Policy and Practice 2019 12:15Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science
Pharmaceutical pricing has only recently gained space in mainstream health science literature.Journal of Pharmaceutical Policy and Practice 2019 12:24A case of DAPSONE INDUCED METHEMOGLOBINEMIA
Methemoglobinemia (MetHb) being a rare cause of cyanosis is generally not considered in its differential diagnosis. Methemoglobinemia is an abnormal Hb produced physiologically by auto-oxidation. If this proce...Journal of Pharmaceutical Policy and Practice 2019 12:22Patient involvement in questionnaire design: tackling response error and burden
Questionnaires capture patient perspectives succinctly and at relatively low cost, making them a popular data collection tool for health researchers. However, questionnaire data can be affected by response err...Journal of Pharmaceutical Policy and Practice 2019 12:17Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone
Few low and middle-income countries (LMIC) have fully operational pharmacovigilance structures, systems and legal framework to collect and collate safety data and evaluate the risks and benefits by active and ...Journal of Pharmaceutical Policy and Practice 2019 12:13Access to and use of medicines in the Annapurna region of Western Nepal and possible impacting factors
Improving access to medicines is a major healthcare challenge for low-income countries because the problem traverses health systems, society and multiple stakeholders. The Annapurna region of Nepal provides a ...Journal of Pharmaceutical Policy and Practice 2019 12:11Current status and future prospects of pharmacovigilance in Pakistan
Countries all around the globe are working to establish robust pharmacovigilance systems. Whereas the majority of the developed countries have established well-organized pharmacovigilance systems, the developi...Journal of Pharmaceutical Policy and Practice 2019 12:14Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study
Existing literature does not provide enough information on evaluation of factors associated with pre-dialysis controlled hypertension among euvolemic hemodialysis (HD) patients. We conducted a study to evaluat...Journal of Pharmaceutical Policy and Practice 2019 12:10Rationing for medicines by health care providers in Indonesia National Health Insurance System at hospital setting: a qualitative study
Universal Health Coverage (UHC) in Indonesia is planned to be fully implemented in 2019 through the National Health Insurance (NHI) launched in January 2014. However, limited financial resources cause health c...Journal of Pharmaceutical Policy and Practice 2019 12:7Assessment of disposal practices of expired and unused medications among community pharmacies in Anambra State southeast Nigeria: a mixed study design
Expired or unused medicines are potentially toxic substances that should be managed effectively to avoid accumulation of potentially toxic pharmaceuticals in the environment. In Nigeria, there is currently lim...Journal of Pharmaceutical Policy and Practice 2019 12:12Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait
In Kuwait, the government is planning to improve the specifications for purchase of medicine and to improve the tendering system intending to slow the growth of the expenditure for medicine and to improve the ...Journal of Pharmaceutical Policy and Practice 2019 12:9Optimization of antibiotic selection in the emergency department for urine culture follow ups, a retrospective pre-post intervention study: clinical pharmacist efforts
Urinary tract infections (UTI) are commonly encountered in the emergency department (ED). ED culture follow up is an important tool to provide the appropriate therapy after the identification of the causative ...Journal of Pharmaceutical Policy and Practice 2019 12:8Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review
Proton pump inhibitors (PPIs) are used worldwide for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Although considered to be widely safe, PPIs have been associated wit...Journal of Pharmaceutical Policy and Practice 2019 12:6Diabetes policies and pharmacy-based diabetes interventions in Portugal: a comprehensive review
Pharmacy-based interventions are complex public health endeavors which include, but are not restricted to, the conventional medication supply role. In diabetes, such interventions may improve patients’ outcome...Journal of Pharmaceutical Policy and Practice 2019 12:5Jazia prime vendor system- a public-private partnership to improve medicine availability in Tanzania: from pilot to scale
The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public healt...Journal of Pharmaceutical Policy and Practice 2019 12:4Self medication practice and associated factors among students of Asmara College of Health Sciences, Eritrea: a cross sectional study
Self-medication is a common practice globally and the resulting irrational drug use is raising concerns. Up-to-date there is no systematic study conducted on self medication practice among students or the gene...Journal of Pharmaceutical Policy and Practice 2019 12:3Inter-rater reliability and validity of good pharmacy practices measures in inspection of public sector health facility pharmacies in Uganda
The National Drug Authority (NDA) inspects and certifies private and public sector pharmacies in Uganda using an indicator-based inspection tool that measures adherence to good pharmacy practices (GPP). 67 mea...Journal of Pharmaceutical Policy and Practice 2019 12:2Use of generic medicines in Latvia: awareness, opinions and experiences of the population
To stimulate use of generic medicines a combination of supply and demand side mechanisms are employed in the Latvian reimbursement system. It is reported that patients have high out-of-pocket pharmaceutical sp...Journal of Pharmaceutical Policy and Practice 2019 12:1To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana
In Ghana, there is extensive over-the-counter dispensing of antibiotics, resulting in high levels of inappropriate use, and an increase in antibiotic resistance. Regulations prevent Licenced Chemical Sellers (...Journal of Pharmaceutical Policy and Practice 2018 11:30Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.
High medicines prices increasingly pose challenges for universal access to treatments of communicable and non-communicable diseases. New essential medicines are often patent-protected which sustains high price...Journal of Pharmaceutical Policy and Practice 2018 11:31Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?
In the United States (U.S.), large price increases for selected generic drugs have elicited public outrage. Recent legislative proposals aim to increase price transparency and identify outlier drug “price spik...Journal of Pharmaceutical Policy and Practice 2018 11:29Assessment of knowledge, attitude and practice towards disposal of unused and expired pharmaceuticals among community in Harar city, Eastern Ethiopia
Pharmaceuticals are produced and consumed in increasing volume every year. Unfortunately, not all medications that go in to the hand of the consumers get consumed; large quantities remain unused or expire. The...Journal of Pharmaceutical Policy and Practice 2018 11:27Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare
Canadians have long been proud of their universal health insurance system, which publicly funds the cost of physician visits and hospitalizations at the point of care. Prescription drugs however, have been sub...Journal of Pharmaceutical Policy and Practice 2018 11:28Access to innovative cancer medicines in a middle-income country - the case of Mexico
Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin Americ...Journal of Pharmaceutical Policy and Practice 2018 11:25Investigation of prescribing behavior at outpatient settings of governmental hospitals in eastern Ethiopia: an overall evaluation beyond World Health Organization core prescribing indicators
Rational prescribing remains an important component of rational drug use. The World Health Organization (WHO) standardized and validated core prescribing indicators for evaluating prescribing pattern of drugs....Journal of Pharmaceutical Policy and Practice 2018 11:26Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy
A strong pharmaceutical sector is a precondition for effective and efficient health care and financing systems, and thus for achieving the best possible health of a population. Supported by visionary, long-ter...Journal of Pharmaceutical Policy and Practice 2018 11:23Trade agreements and drug access: assessment of the impact of the 2009 Peruvian new drug policy on anti-infectives registration and availability
The United States-Peru Free Trade Agreement required changes in the Peruvian pharmaceutical legislation that resulted in the National Drug Policy (NDP) of 2009. This study evaluated the registration of brand a...Journal of Pharmaceutical Policy and Practice 2018 11:24Country ownership and sustainability of Nigeria’s HIV/AIDS Supply Chain System: qualitative perceptions of progress, challenges and prospects
The emergency response phase to HIV epidemic in Nigeria and other countries saw to the deployment of donors’ resources with little consideration for country ownership (CO) and sustainability. The progress that...Journal of Pharmaceutical Policy and Practice 2018 11:21An analysis of pharmacy workforce capacity in Nigeria
Pharmacists are critical for attaining the goal of universal health coverage and equitable access to essential health services, particularly in relation to access to medicines and medicines expertise. We descr...Journal of Pharmaceutical Policy and Practice 2018 11:20The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature
In Australia, community pharmacists are increasingly being integrated into the healthcare system. A range of services in pharmacies are government-funded aiming to prevent chronic diseases and improve the qual...Journal of Pharmaceutical Policy and Practice 2018 11:22Perceptions of the Malaysian general public on community pharmacy-based weight management services
Obesity is now widely regarded as a main contributor to poor health. Involvement of community pharmacists can be a valuable tool in obesity management. However, there is still a lack of data in Malaysia on the...Journal of Pharmaceutical Policy and Practice 2018 11:17
No hay comentarios:
Publicar un comentario